| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0885-3924(02)00529-8 |
| P698 | PubMed publication ID | 12551804 |
| P50 | author | David T Eton | Q73276224 |
| P2093 | author name string | David Cella | |
| Jin-Shei Lai | |||
| Amy H Peterman | |||
| Douglas E Merkel | |||
| P2860 | cites work | Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life | Q33845173 |
| Measurement of health status. Ascertaining the minimal clinically important difference | Q34515517 | ||
| Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms | Q34590626 | ||
| Improving quality of life in patients with non-small cell lung cancer: research experience with gemcitabine | Q39459263 | ||
| Interpretation of quality of life changes | Q40860487 | ||
| Measuring health-related quality of life | Q40885951 | ||
| Interpreting treatment effects in randomised trials | Q41729509 | ||
| Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group | Q42651559 | ||
| Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. | Q50861786 | ||
| Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. | Q51044933 | ||
| The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue | Q52017423 | ||
| Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. | Q53483740 | ||
| Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. | Q53483744 | ||
| Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. | Q53510246 | ||
| Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. | Q53539831 | ||
| Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. | Q53576649 | ||
| Interpreting the significance of changes in health-related quality-of-life scores. | Q53584979 | ||
| Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. | Q53665742 | ||
| Completeness of reporting trial results: effect on physicians' willingness to prescribe | Q72676670 | ||
| Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system | Q73206828 | ||
| The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory | Q74635584 | ||
| Fatigue in patients with cancer | Q77809252 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 547-561 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Journal of Pain and Symptom Management | Q6295708 |
| P1476 | title | Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales | |
| P478 | volume | 24 |
| Q33531344 | 'Pragmatic randomized controlled trial of individually prescribed exercise versus usual care in a heterogeneous cancer survivor population': a feasibility study PEACH trial: prescribed exercise after chemotherapy |
| Q37551843 | A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab |
| Q34477467 | A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy |
| Q34561380 | A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors |
| Q39858986 | A novel approach to estimate the minimally important difference for the Fatigue Impact Scale in multiple sclerosis patients |
| Q36621368 | A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlle |
| Q89639094 | A physical activity intervention to improve the quality of life of patients with a stoma: a feasibility study |
| Q93003368 | A physical activity intervention to improve the quality of life of patients with a stoma: a feasibility study protocol |
| Q34079166 | A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy |
| Q48039850 | A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer |
| Q90139105 | A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures |
| Q27331496 | A randomized trial comparing live and telemedicine deliveries of an imagery-based behavioral intervention for breast cancer survivors: reducing symptoms and barriers to care |
| Q33579085 | A randomized trial of weekly symptom telemonitoring in advanced lung cancer |
| Q92025230 | A review of prostate cancer treatment impact on the CNS and cognitive function |
| Q34284843 | A structured exercise program for patients with advanced non-small cell lung cancer |
| Q34019470 | ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials |
| Q35871611 | Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice |
| Q92727367 | Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial to improve quality of life: a study protocol for a randomized clinical trial |
| Q34065177 | Age-associated differences in fatigue among patients with cancer |
| Q58582886 | Altered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer Patients |
| Q48075626 | Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy |
| Q34502821 | An evaluation of the St Christopher's Hospice rehabilitation gym circuits classes: Patient uptake, outcomes, and feedback |
| Q39620807 | An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases. |
| Q48459981 | Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks |
| Q44901457 | Assessing the effect of darbepoetin alfa on patient-reported fatigue in chemotherapy-induced anemia in four randomized, placebo-controlled clinical trials |
| Q53091807 | Association Between Anemia and Fatigue in Hospitalized Patients: Does the Measure of Anemia Matter? |
| Q42168865 | Association between Daytime Activity, Fatigue, Sleep, Anxiety, Depression, and Symptom Burden in Advanced Cancer Patients: A Preliminary Report |
| Q50532106 | Association of Fatigue Intensification with Cognitive Impairment during Radiation Therapy for Prostate Cancer. |
| Q47383431 | Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors |
| Q53193088 | Associations between physical activity and quality of life in ovarian cancer survivors. |
| Q48074092 | Associations of objectively assessed physical activity and sedentary time with health-related quality of life among colon cancer survivors |
| Q33558763 | Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry |
| Q37195095 | Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis |
| Q35225405 | Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia |
| Q38422074 | Cancer-related fatigue and associated disability in post-treatment cancer survivors |
| Q92366440 | Cancer‑related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction |
| Q92998865 | Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study |
| Q33795277 | Classical homeopathy in the treatment of cancer patients--a prospective observational study of two independent cohorts |
| Q37807316 | Clinical Practice Guidelines for the Use of Erythroid-Stimulating Agents: ASCO, EORTC, NCCN |
| Q28652859 | Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials |
| Q92586723 | Cognitive and motor aspects of cancer-related fatigue |
| Q36723331 | Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial. |
| Q36219570 | Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients |
| Q33727356 | Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial |
| Q40026261 | Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors |
| Q30439889 | Computerized adaptive testing for follow-up after discharge from inpatient rehabilitation: II. Participation outcomes. |
| Q39197018 | Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation. |
| Q35570918 | Construct validity and minimal important difference of 6-minute walk distance in survivors of acute respiratory failure |
| Q61810499 | Content validity and psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with psoriatic arthritis |
| Q92179428 | Content validity and psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with psoriatic arthritis |
| Q37401283 | Criterion validation of the rate of recovery, a single alphanumeric measure, in patients with shoulder pain |
| Q34751907 | Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial |
| Q47246762 | Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline |
| Q40209980 | Design of a randomized trial to determine the optimum protein intake to preserve lean body mass and to optimize response to a promyogenic anabolic agent in older men with physical functional limitation |
| Q48851710 | Determinants of quality of life in patients with advanced cancer |
| Q90235940 | Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery |
| Q39977054 | Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population |
| Q36961592 | Development and psychometric properties of the PROMIS(®) pediatric fatigue item banks |
| Q84568859 | Development of an electronic daily uterine fibroid symptom diary |
| Q35090621 | Diet and physical activity intervention in colorectal cancer survivors: a feasibility study |
| Q37587863 | Diet components associated with perceived fatigue in breast cancer survivors |
| Q50308378 | Different Phenotyping Approaches Lead to Dissimilar Biologic Profiles in Men With Chronic Fatigue After Radiation Therapy |
| Q47555069 | Differential effects of early palliative care based on the age and sex of patients with advanced cancer from a randomized controlled trial |
| Q59789299 | Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review |
| Q47140896 | Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients |
| Q24242050 | Drug therapy for the management of cancer related fatigue |
| Q24234267 | Drug therapy for the management of cancer-related fatigue |
| Q24243141 | Drugs for the treatment of fatigue in palliative care |
| Q37766575 | Economic evaluation of erythropoiesis-stimulating agents for anemia related to cancer |
| Q92346712 | Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry |
| Q24193045 | Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria |
| Q37810103 | Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria |
| Q51763693 | Effect of Protein Intake on Lean Body Mass in Functionally Limited Older Men: A Randomized Clinical Trial. |
| Q88853388 | Effect of a spiritual care training program for staff on patient outcomes |
| Q34336573 | Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial |
| Q48666474 | Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level |
| Q36673441 | Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report |
| Q30833686 | Effects of Testosterone Treatment in Older Men. |
| Q47587563 | Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial. |
| Q48137037 | Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan. |
| Q30803363 | Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data |
| Q34696044 | Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis |
| Q97904990 | Effects of high-intensity interval training compared with resistance training in prostate cancer patients undergoing radiotherapy: a randomized controlled trial |
| Q88596903 | Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors |
| Q47120245 | Effects of the community-based Wellspring Cancer Exercise Program on functional and psychosocial outcomes in cancer survivors |
| Q33692432 | Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer. |
| Q34470847 | Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron |
| Q42132869 | Emotional acceptance, inflammation, and sickness symptoms across the first two years following breast cancer diagnosis |
| Q92165252 | Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors |
| Q35584293 | Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial |
| Q34766141 | Erythropoietin improves quality of life |
| Q24202335 | Erythropoietin or darbepoetin for patients with cancer |
| Q47869113 | Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol |
| Q36471118 | Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer |
| Q38410039 | Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. |
| Q97419332 | Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial |
| Q37551087 | Evaluating Physical Outcomes in Acute Respiratory Distress Syndrome Survivors: Validity, Responsiveness, and Minimal Important Difference of 4-Meter Gait Speed Test |
| Q37015284 | Evaluating the reliability, validity and minimally important difference of the Taiwanese version of the diabetes quality of life (DQOL) measurement |
| Q90125971 | Evaluation of Clinically Meaningful Changes in Measures of Frailty |
| Q37015822 | Exercise Interventions for Cancer Survivors: A Meta-Analysis of Quality of Life Outcomes |
| Q24202860 | Exercise for the management of cancer-related fatigue in adults |
| Q24243135 | Exercise for the management of cancer-related fatigue in adults |
| Q38815010 | Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy. |
| Q50082447 | Expression of Sestrin Genes in Radiotherapy for Prostate Cancer and Its Association With Fatigue: A Proof-of-Concept Study |
| Q47570348 | Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial |
| Q90370685 | Fatigue in IBD: epidemiology, pathophysiology and management |
| Q50910513 | Fatigue in older adults with acute myeloid leukemia: predictors and associations with quality of life and functional status. |
| Q52561167 | Fatigue, Pain, and other Physical Symptoms of Living Liver Donors in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL-2). |
| Q90067703 | Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT): a randomised trial protocol |
| Q95260062 | Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design |
| Q89908506 | Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer |
| Q44383537 | Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial. |
| Q50145660 | Feasibility and preliminary efficacy of an exercise telephone counseling intervention for hematologic cancer survivors: a phase II randomized controlled trial |
| Q37098701 | Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders |
| Q98292908 | Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS Registry |
| Q47343902 | Gene Expression, and Fatigue in Puerto Rican Men during Radiotherapy for Prostate Cancer: an Exploratory Study |
| Q58700922 | Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron |
| Q43798489 | Hematological variables and iron status in abdominoplasty after bariatric surgery |
| Q40014607 | Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study |
| Q39521011 | Impact of Microarray Preprocessing Techniques in Unraveling Biological Pathways |
| Q36987497 | Impact of erythropoietin treatment on the quality of life of oncologic patients |
| Q36080601 | Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment |
| Q33676785 | Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial |
| Q34307724 | Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer |
| Q37952140 | Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations |
| Q90018185 | Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell Carcinoma |
| Q91698142 | Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
| Q90280913 | Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trial |
| Q51764565 | Lessons from the Testosterone Trials. |
| Q30461151 | Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: which differences are clinically important? |
| Q33754654 | Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns |
| Q89047688 | Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy |
| Q53199973 | Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. |
| Q53185573 | Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. |
| Q30558852 | Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation |
| Q36573055 | Lower brain-derived neurotrophic factor levels associated with worsening fatigue in prostate cancer patients during repeated stress from radiation therapy. |
| Q102379345 | MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study |
| Q64057957 | Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update |
| Q91248965 | Management of fatigue in children and adolescents with cancer and in paediatric recipients of haemopoietic stem-cell transplants: a clinical practice guideline |
| Q33636961 | Meaningful change in measures of gait variability in older adults |
| Q91253123 | Meaningful differences and validity for the NCCN/FACT-P Symptom Index: An analysis of the ALSYMPCA data |
| Q55379461 | Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease. |
| Q36160569 | Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire |
| Q36951725 | Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial |
| Q36069816 | Minimal important differences for fatigue patient reported outcome measures-a systematic review |
| Q39831894 | Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials |
| Q36861963 | Minimally important differences for Patient Reported Outcomes Measurement Information System pain interference for individuals with back pain |
| Q97080064 | Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer |
| Q34790020 | Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients |
| Q80788572 | Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial |
| Q42846497 | Move onward, press forward, and take a deep breath: can lifestyle interventions improve the quality of life of women with breast cancer, and how can we be sure? |
| Q90337679 | Nutrition therapy for the management of cancer-related fatigue and quality of life: a systematic review and meta-analysis |
| Q36238990 | Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol |
| Q36852329 | Oncology Section EDGE Task Force on Prostate Cancer: A Systematic Review of Outcome Measures for Health-Related Quality of Life |
| Q24811022 | Order effects: a randomised study of three major cancer-specific quality of life instruments |
| Q38808502 | Pain Measurement in Children with Functional Abdominal Pain. |
| Q88093383 | Paroxysmal nocturnal haemoglobinuria |
| Q92019648 | Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial |
| Q39312586 | Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life |
| Q91734391 | Patients with adolescent idiopathic scoliosis perceive positive improvements regardless of change in the Cobb angle - Results from a randomized controlled trial comparing a 6-month Schroth intervention added to standard care and standard care alone. |
| Q26770413 | Pazopanib in the treatment of advanced renal cell carcinoma |
| Q91590032 | Peer support for the maintenance of physical activity and health in cancer survivors: the PEER trial - a study protocol of a randomised controlled trial |
| Q52714644 | Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis. |
| Q24187756 | Pharmacological treatments for fatigue associated with palliative care |
| Q24236457 | Pharmacological treatments for fatigue associated with palliative care |
| Q37125405 | Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes |
| Q36082496 | Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue |
| Q45093247 | Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma. |
| Q96949271 | Physical activity and exercise in women with ovarian cancer: A systematic review |
| Q47552618 | Physical activity for women with breast cancer after adjuvant therapy. |
| Q39983194 | Physical activity is associated with clinically important differences in health-related quality of life among rural and small-town breast cancer survivors |
| Q35904706 | Physical and mental health status and health behaviors of childhood cancer survivors: findings from the 2009 BRFSS survey |
| Q41125493 | Physiotherapy programme reduces fatigue in patients with advanced cancer receiving palliative care: randomized controlled trial. |
| Q58612429 | Pilot Study to Describe the Trajectory of Symptoms and Adaptive Strategies of Adults Living with Low-grade Glioma |
| Q44029537 | Pilot, randomized trial of resistance exercise during radiation therapy for head and neck cancer |
| Q92848493 | Prevalence and factors associated with fatigue in the Lausanne middle-aged population: a population-based, cross-sectional survey |
| Q53061269 | Prospective evaluation of the reliability, validity, and minimally important difference of the functional assessment of cancer therapy-gastric (FACT-Ga) quality-of-life instrument. |
| Q44486995 | Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer |
| Q35071645 | Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis |
| Q34751523 | Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer |
| Q50956582 | Quality of life and mental health in cervical and endometrial cancer survivors. |
| Q33288995 | Quality of life of Lithuanian women with early stage breast cancer |
| Q26774542 | Quality of life: A critical outcome for all surgical treatments of gastric cancer |
| Q53226503 | Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. |
| Q60473145 | Qualité de vie et traitement de l’anémie chimio-induite dans le cancer bronchopulmonaire : étude prospective |
| Q45058787 | Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016. |
| Q90570386 | Randomized Trial of Exercise on Quality of Life in Women With Ovarian Cancer: Women's Activity and Lifestyle Study in Connecticut (WALC) |
| Q35284912 | Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures |
| Q53217666 | Rapid detection of differential item functioning in assessments of health-related quality of life: The Functional Assessment of Cancer Therapy. |
| Q58768520 | Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer |
| Q42656571 | Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy |
| Q47751241 | Refinement and revalidation of the demoralization scale: The DS-II-external validity |
| Q45022467 | Relationship of Mitochondrial Enzymes to Fatigue Intensity in Men With Prostate Cancer Receiving External Beam Radiation Therapy. |
| Q60750540 | Relationship of hemoglobin, fatigue, and quality of life in anemic cancer patients |
| Q37289296 | Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization |
| Q82275296 | Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT) |
| Q53932137 | Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer |
| Q38684252 | Responsiveness and Minimally Important Differences for 4 Patient-Reported Outcomes Measurement Information System Short Forms: Physical Function, Pain Interference, Depression, and Anxiety in Knee Osteoarthritis |
| Q37594749 | Restorative yoga for women with breast cancer: findings from a randomized pilot study |
| Q30650394 | Review of health-related quality of life data in multiple myeloma patients treated with novel agents |
| Q33432637 | Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial |
| Q80514612 | Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. |
| Q90447853 | Tailored exercise interventions to reduce fatigue in cancer survivors: study protocol of a randomized controlled trial |
| Q48477274 | Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial |
| Q34478536 | The Alberta moving beyond breast cancer (AMBER) cohort study: a prospective study of physical activity and health-related fitness in breast cancer survivors. |
| Q41584179 | The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial |
| Q24807048 | The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation |
| Q89838225 | The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index |
| Q60716148 | The Relationship Between Patient Knowledge of Hemoglobin Levels and Health-Related Quality of Life |
| Q34276276 | The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. |
| Q36270377 | The Women's wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol. |
| Q64936096 | The association of pain and stiffness with fatigue in incident polymyalgia rheumatica: baseline results from the polymyalgia rheumatica cohort study. |
| Q36516476 | The clinical significance of quality of life assessments in oncology: a summary for clinicians |
| Q47744787 | The effect of physical activity on fatigue among survivors of colorectal cancer: a systematic review and meta-analysis. |
| Q34502538 | The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol |
| Q48344046 | The minimal clinical important difference in the World Health Organization Quality of Life instrument--100. |
| Q64124616 | The modified Memorial Symptom Assessment Scale Short Form: a modified response format and rational scoring rules |
| Q34473328 | The potential role of exercise in neuro-oncology |
| Q87671063 | The role of TRAIL in fatigue induced by repeated stress from radiotherapy |
| Q38817011 | The use of exercise interventions to overcome adverse effects of androgen deprivation therapy. |
| Q37517338 | Translation and validation of the Cancer-Related Fatigue Scale in Greek in a sample of patients with advanced prostate cancer. |
| Q53202348 | Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3)). |
| Q36969956 | Understanding breast cancer patients' preference for two types of exercise training during chemotherapy in an unblinded randomized controlled trial. |
| Q47121919 | Validation of a health-related quality of life instrument for primary ciliary dyskinesia (QOL-PCD). |
| Q33395130 | Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia |
| Q40359664 | Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole. |
| Q47646426 | Web-Based Stress Management for Newly Diagnosed Patients With Cancer (STREAM): A Randomized, Wait-List Controlled Intervention Study |
| Q36181384 | Web-based stress management for newly diagnosed cancer patients (STREAM-1): a randomized, wait-list controlled intervention study |
| Q102220529 | What is the minimal dose for resistance exercise effectiveness in prostate cancer patients? Systematic review and meta-analysis on patient-reported outcomes |
| Q63532871 | Whole Body Vibration Exposure on Markers of Bone Turnover, Body Composition, and Physical Functioning in Breast Cancer Patients Receiving Aromatase Inhibitor Therapy: A Randomized Controlled Trial |
| Q64113481 | eHealth-based intervention to increase physical activity levels in people with cancer: protocol of a feasibility trial in an Irish acute hospital setting |
| Q55261484 | mGluR5 mediates post-radiotherapy fatigue development in cancer patients. |
Search more.